Movement Alert｜Oscar Health, Inc. Rises 5.09% in Regular Trading, Strong Q2 Earnings and Analyst Upgrades Continue to Drive Momentum

Market Focus08-13 03:11

On August 13, Oscar Health, Inc. rose 5.09% in regular trading, trading at $29.35/share, with turnover of $118 million. The stock continued to rally following strong Q2 results and multiple analyst upgrades.

Oscar Health reported Q2 EPS of $1.10, far exceeding the consensus estimate of $0.49 and swinging from a loss of $0.89 per share a year earlier. Revenue reached $4.88 billion, up from $2.86 billion year-over-year, also beating analyst expectations of $4.75 billion. Total effectuated membership surged 46% year-over-year to 2.963 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above FactSet estimates of $18.55 billion.

On the analyst front, UBS raised its price target to $26 from $20 on August 7 while maintaining a Neutral rating. Barclays previously upgraded the stock to Overweight and raised its target to $35. Despite management warning that ACA membership churn may accelerate in the second half, the fundamental outperformance continues to attract capital inflows.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150215959?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-13 03:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150215959","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Oscar Health, Inc. Rises 5.09% in Regular Trading, Strong Q2 Earnings and Analyst Upgrades Continue to Drive Momentum","media":"Market Focus","content":"<p><p>On August 13, Oscar Health, Inc. rose 5.09% in regular trading, trading at $29.35/share, with turnover of $118 million. The stock continued to rally following strong Q2 results and multiple analyst upgrades.</p><p>Oscar Health reported Q2 EPS of $1.10, far exceeding the consensus estimate of $0.49 and swinging from a loss of $0.89 per share a year earlier. Revenue reached $4.88 billion, up from $2.86 billion year-over-year, also beating analyst expectations of $4.75 billion. Total effectuated membership surged 46% year-over-year to 2.963 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above FactSet estimates of $18.55 billion.</p><p>On the analyst front, UBS raised its price target to $26 from $20 on August 7 while maintaining a Neutral rating. Barclays previously upgraded the stock to Overweight and raised its target to $35. Despite management warning that ACA membership churn may accelerate in the second half, the fundamental outperformance continues to attract capital inflows.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Oscar Health, Inc. Rises 5.09% in Regular Trading, Strong Q2 Earnings and Analyst Upgrades Continue to Drive Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Oscar Health, Inc. Rises 5.09% in Regular Trading, Strong Q2 Earnings and Analyst Upgrades Continue to Drive Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-13 03:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 13, Oscar Health, Inc. rose 5.09% in regular trading, trading at $29.35/share, with turnover of $118 million. The stock continued to rally following strong Q2 results and multiple analyst upgrades.</p><p>Oscar Health reported Q2 EPS of $1.10, far exceeding the consensus estimate of $0.49 and swinging from a loss of $0.89 per share a year earlier. Revenue reached $4.88 billion, up from $2.86 billion year-over-year, also beating analyst expectations of $4.75 billion. Total effectuated membership surged 46% year-over-year to 2.963 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above FactSet estimates of $18.55 billion.</p><p>On the analyst front, UBS raised its price target to $26 from $20 on August 7 while maintaining a Neutral rating. Barclays previously upgraded the stock to Overweight and raised its target to $35. Despite management warning that ACA membership churn may accelerate in the second half, the fundamental outperformance continues to attract capital inflows.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1150215959","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150215959","pubTimestamp":1786561906,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 13, Oscar Health, Inc. rose 5.09% in regular trading, trading at $29.35/share, with turnover of $118 million. The stock continued to rally following strong Q2 results and multiple analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"走势警报|Oscar Health, Inc. 常规交易上涨 5.09%，强劲的第二季度盈利和分析师升级继续推动势头","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"On August 13, Oscar Health, Inc. rose 5.09% in regular trading, trading at $29.35/share, with turnover of $118 million. The stock continued to rally following strong Q2 results and multiple analyst upgrades.Oscar Health reported Q2 EPS of $1.10, far exceeding the consensus estimate of $0.49 and swinging from a loss of $0.89 per share a year earlier. Revenue reached $4.88 billion, up from $2.86 billion year-over-year, also beating analyst expectations of $4.75 billion. Total effectuated membership surged 46% year-over-year to 2.963 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above FactSet estimates of $18.55 billion.On the analyst front, UBS raised its price target to $26 from $20 on August 7 while maintaining a Neutral rating. Barclays previously upgraded the stock to Overweight and raised its target to $35. Despite management warning that ACA membership churn may accelerate in the second half, the fundamental outperformance continues to attract capital inflows.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150215959","isCrawlerRequest":true}